BIOMARIN PHARMACEUTICAL INC (BMRN) Operating Lease, Right-of-Use Asset USD 2019 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Biomarin Pharmaceutical Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from 2019 to 2023.
  • Biomarin Pharmaceutical Inc Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2023 was $42.7 M, a 22.3% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly Data (USD)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $42.7 M +$7.8 M +22.3% Dec 31, 2023 10-K 2024-02-26
Q4 2022 $34.9 M -$3.26 M -8.54% Dec 31, 2022 10-K 2024-02-26
Q4 2021 $38.2 M -$7.82 M -17% Dec 31, 2021 10-K 2023-02-27
Q4 2020 $46 M -$3.03 M -6.18% Dec 31, 2020 10-K 2022-02-25
Q3 2020 $45.8 M -$5.52 M -10.8% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $47.2 M -$3.95 M -7.72% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $49.1 M +$4.89 M +11.1% Mar 31, 2020 10-Q 2020-05-01
Q4 2019 $49 M Dec 31, 2019 10-K 2021-02-26
Q3 2019 $51.3 M Sep 30, 2019 10-Q/A 2019-11-04
Q2 2019 $51.2 M Jun 30, 2019 10-Q 2019-08-02
Q1 2019 $44.2 M Mar 31, 2019 10-Q 2019-04-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.